resolution characterization of chromosomal abnormalities down to the kilobase level, whereas previous studies on desmoidtumorshavelargelyemployedtechniquessuitedfor thedetectionofmegabaseorlargerchromosomalalterations [14] .InconjunctionwithSNP-A,theauthorsperformedtraditional DNA sequencing on a number of genes known to be mutated in desmoid tumors, including β-catenin (CTNNB1) andAPC.
Using these combined methodologies, the authors validatedexistingdataonthepresenceofmutationsinCTNNB1, andlossesinchromosome8q,whichcontainstheAPClocus. Inaddition,theydetectednumerousothersmalldeletionsand insertionsthathavepreviouslynotbeenreportedindesmoid tumors.Themostsignificantofthesenovellesionswasaheterozygous,somaticdeletionaffectingasmallregionofchromosome 8p23, which was observed in 44% of the tumors tested.ThisdeletionfallswithintheCUB and Sushi multiple domains1(CSMD1)gene,aputativetumorsuppressorthatis also mutated or deleted in tumors of the head and neck, colon,breast,andprostate [15, 16] .Furthermore,theauthors notedacorrelationbetweenCSMD1deletionandrelapse,as 3ofthe9patientswithdiseaserecurrenceatthetimeofpub-lication had exhibited a CSMD1 deletion. The small sample sizeandshortfollow-uptimelimittheauthors'abilitytomake firmconclusionsregardingtheprognosticsignificanceofthese otherwiseexceptionalandnoveldata.
The management of desmoid tumors remains a challenge to the patient and the clinician. However, studies such as thisbyErbenandcolleaguesaddtothearsenalofdatathat willeventuallyleadtonoveltherapiesforthisdisease.Asfor all patients presenting with complex malignancies such as desmoid tumors, continued efforts for tissue collection and multi-institutionandprotocol-basedregimensarejustified.
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Desmoidtumorshavelongbeenknownasan'enigma'dueto their unusual biology and aggressive clinical behavior [1] [2] [3] . Thesetumorsmayarisefromtheextremities,abdominalwall, intestinalwallandmesentery,headandneck,andbreastand canbesporadicorassociatedwithfamilialadenomatouspolyposis [4] [5] [6] [7] [8] [9] . Despite being histologically benign tumors, desmoids are locally aggressive and can cause debilitating symptomsanddeath [10] .Ithasbeenreportedthataggressive measurestosurgicallyextirpatedesmoidtumorscanresultin significant morbidity and mortality, which has resulted in changesinmanagementoftheselesions [4] .Alternativessuch asobservation,radiation,andchemo/hormonaltherapyhave been explored, but with unproven durable success [11, 12] . Molecular and genetic characterization of desmoid tumors mustbedoneinordertoultimatelydevelopnovel,effective targetsfortherapy.
Severalstudieshavebeenperformedtobeginto'decrypt' theseenigmatictumorsinanefforttobetterunderstandthe etiologyandgeneticmachinerybehindthisdisease.Asample of studies is shown in table 1. Many of the studies to date have found signaling changes in the β-catenin pathway, and in addition, chromosomal alterations. From these studies, it is reasonable to conclude that desmoid tumors are highly heterogeneousandrequirefurtherinvestigation.
InthisissueofOnkologie,Erbenandcolleaguescomprehensively evaluate 9 patients with desmoid tumors of the abdomen(n=7)andextremity(n=2);8/9weresporadicdes-moids while 1 patient had familial adenomatous polyposis [13] . Resection only was the treatment for 4 patients while 5patientshadradiationtherapy,1patientchemotherapy,and 2 patients hormonal therapy. 3 patients recurred during the follow-upperiod.Despitethisbeingasmallsamplesize,itisa snapshotrepresentationofpatientswithdesmoidtumorswho areoftentreatedwithmultimodalitytherapy. 
